Thomas R. Hird
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology 1
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Diabetes Management and Research 2
-
- Global Public Health Policies and Epidemiology 4
-
- Health Policy Implementation Science 2
-
- Chronic Disease Management Strategies 4
-
- Healthcare Systems and Reforms 3
-
- Smoking Behavior and Cessation 3
- Co-authors
- Nicholas C. GrasslyDianna J. MaglianoDanny LiewElla ZomerAlice OwenZanfina AdemiTonya M. EsterhuizenAyesha A. Motala
- Cited by
- Cardiology and Cardiovascular MedicineInfectious DiseasesEndocrinology, Diabetes and Metabolism
- Partner nations
- United KingdomAustraliaSouth Africa
In The Last Decade
Thomas R. Hird
17 papers receiving 466 citations
Peers
Comparison fields: 5 of 83
- Cardiology and Cardiovascular Medicine 188
- Infectious Diseases 150
- Endocrinology, Diabetes and Metabolism 101
- Organizational Behavior and Human Resource Management 51
- General Health Professions 74
Countries citing papers authored by Thomas R. Hird
This map shows the geographic impact of Thomas R. Hird's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas R. Hird with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas R. Hird more than expected).
Fields of papers citing papers by Thomas R. Hird
This network shows the impact of papers produced by Thomas R. Hird. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas R. Hird. The network helps show where Thomas R. Hird may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas R. Hird, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2022 | 8 | |
| 3 | 2022 | 20 | |
| 4 | 2021 | 3 | |
| 5 | Tobacco industry tactics to undermine tobacco control. | 2021 | 0 |
| 6 | The two faces of the tobacco industry during the COVID-19 pandemic | 2020 | 5 |
| 7 | 2020 | 43 | |
| 8 | 2020 | 25 | |
| 9 | 2019 | 16 | |
| 10 | 2019 | 40 | |
| 11 | 2019 | 3 | |
| 12 | 2019 | 2 | |
| 13 | 2019 | 65 | |
| 14 | 2018 | 16 | |
| 15 | 2016 | 17 | |
| 16 | 2016 | 40 | |
| 17 | Lessons from Ebola affected communities: Being prepared for future health crises | 2016 | 4 |
| 18 | 2012 | 161 |
About Thomas R. Hird
Thomas R. Hird is a scholar working on Organizational Behavior and Human Resource Management, Endocrinology, Diabetes and Metabolism and Finance, having authored 18 papers that have together received 473 indexed citations. Recurring topics across this work include Chronic Disease Management Strategies (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Global Public Health Policies and Epidemiology (4 papers), Healthcare Systems and Reforms (3 papers), Smoking Behavior and Cessation (3 papers), Health Policy Implementation Science (2 papers), Diabetes Management and Research (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). The work is most often cited by research in Cardiology and Cardiovascular Medicine (188 citations), Infectious Diseases (150 citations) and Endocrinology, Diabetes and Metabolism (101 citations). Thomas R. Hird has collaborated with scholars based in United Kingdom, Australia and South Africa. Frequent co-authors include Nicholas C. Grassly, Dianna J. Magliano, Danny Liew, Ella Zomer, Alice Owen, Zanfina Ademi, Tonya M. Esterhuizen, Ayesha A. Motala, Mark I. McCarthy and Lei Chen. Their work appears in journals such as PLoS ONE, Diabetes and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.